The nation of Zimbabwe has declined a major US health deal worth 367 million US dollars (272 million pounds) over five years due to the United States' insistence on sensitive data.
The decision came to light after a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa felt the agreement was "unbalanced".
An official spokesperson has since explained that the United States was demanding access to biological samples for research and profit but was not willing to share the benefits from future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for further dialogue to reach a agreement suitable to all parties so the country's critical HIV programme can continue.
Wider Background
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court suspended a related deal with the US following concerns were raised about the security of Kenyans' health data.
Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had managed aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost transparency and accountability.
According to statements, Sixteen nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership would have delivered immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information over an extended period, with no corresponding promise of access to any scientific breakthroughs – like new medicines or tests – that might result from that shared data," his statement read.
"In essence, our country would provide the basic resources for medical research without any assurance that the end products would be available to our citizens should a new health crisis arise."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting structures already established via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.
"This framework is designed to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to continued dialogue with our US partners on how future collaboration might be designed in a manner that respects the sovereignty and interests of each country."
Medical Community Reaction
Medical experts said it acknowledged the government's concerns, but suggested that talks should continue since much of the nation's HIV programmes relied on international support.
"If technical issues exist, such as those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," it commented.
The halted deal underscores the continuing tensions between accepting vital international aid and safeguarding local interests in an ever more data-driven world.